Published at LXer:
Techdirt has written a few times about the pharmaceutical industry's use of "evergreening", whereby small, sometimes trivial, changes are made to drugs in order to extend their effective patent life. It turns out the technique is applied to one of the most widely-used drugs of all, insulin:
Read More...